COVID-19 rapid antigen testing strategies require careful evaluation.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Understanding the acceptability of COVID-19 antigen rapid diagnostic tests: A multi-country qualitative study.PLOS global public health · 2025
   Article
2. Performance of 20 rapid antigen detection tests to detect SARS-CoV-2 B.1.617.2 (Delta) and B.1.1.529 (Omicron) variants using a clinical specimen panel from January 2022, Berlin, Germany.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023
   Article
3. COVID-19 infection rates and mitigation strategies in orthodontic practices.BMC oral health · 2023
   Article
4. Investigating the Sensitivity of Nasal or Throat Swabs: Combination of Both Swabs Increases the Sensitivity of SARS-CoV-2 Rapid Antigen Tests.Microbiology spectrum · 2022
   Article
5. China's NMPA perspective on the clinical performance of SARS-CoV-2 antigen test reagents.Bioanalysis · 2022
   Review
6. Development, Analytical, and Clinical Evaluation of Rapid Immunochromatographic Antigen Test for SARS-CoV-2 Variants Detection.Diagnostics (Basel, Switzerland) · 2022
   Article
7. Clinical evaluation of the Diagnostic Analyzer for Selective Hybridization (DASH): a point-of-care PCR test for rapid detection of SARS-CoV-2 infection.medRxiv : the preprint server for health sciences · 2022
   Article
8. Rapid antigen testing as a reactive response to surges in nosocomial SARS-CoV-2 outbreak risk.Nature communications · 2022
   Article
9. Clinical evaluation of the Diagnostic Analyzer for Selective Hybridization (DASH): A point-of-care PCR test for rapid detection of SARS-CoV-2 infection.PloS one · 2022
   Article
10. Utility of Point-of-Care COVID-19 Testing in an Outpatient Otolaryngology clinic.OTO open
    Article

Corrections and comments

• Comment on
  Clinical performance evaluation of SARS-CoV-2 rapid antigen testing in point of care usage in comparison to RT-qPCR.2021

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as